Tag: Patricia Kovacevic
Patricia Kovacevic: In May 2016, both sides of the Atlantic entered...
Vaping Post: Now in 2017, what do you retain from the year 2016?
"Only 10 days before the EU revised Tobacco Products Directive compliance deadline an...
Clive Bates: An incredible regulatory process for Ecigs in the USA
Interviewed by Patricia Kovacevic, General Counsel and Chief Compliance Officer at Nicopure Labs, Clive Bates is questioned about his perspective of the regulatory framework the e-cigarette...
Last registrations for E-cigarette conference 2016
The conference is being organized by consultants and event organizers Smithers Rapra, and will be taking place between the 6th and 7th December, at...
Ecigs and therapeutic claim, what is the risk and where do...
Over 6 months (January - June 2015) advertising by 23 leading e-cigarette brands through social media channels and blogs as well as user-generated content (testimonials) appearing within...
Focus: Legal challenge of the US Vaping Industry against the FDA,...
Update on October 12, 2016.
Yesterday was the Motions Hearing at the DC Court.
All went as reasonable as possible. Difficult to predict outcomes, but challenging...
FDA: A gloomy future for the US vaping business
What is your position regarding the future regulation of the FDA?
Patricia Kovacevic: First, a little reminder. In 2009, the US Congress passed the Family...
US FDA’s Final Deeming Rule viewed by an expert
Patricia Kovacevic, General Counsel and Chief Compliance Officer (Nicopure Labs), has communicated throughout the rulemaking process to inform the public of what to expect when...
Nicopure announces legal action against FDA’s deeming rule
"Today we turn to the justice system to protect our rights and the rights of our customers because we believe in its fairness" -P....
